Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy

In spite of significant advances in treatment options and the advent of novel targeted therapies, there still remains an unmet need for the identification of novel pharmacological agents for cancer therapy. This has led to several studies evaluating the possible application of natural agents found i...

Full description

Bibliographic Details
Main Authors: Ko, J., Arfuso, Frank, Sethi, G., Ahn, K.
Format: Journal Article
Published: MDPI AG 2018
Online Access:http://hdl.handle.net/20.500.11937/74245
_version_ 1848763219534938112
author Ko, J.
Arfuso, Frank
Sethi, G.
Ahn, K.
author_facet Ko, J.
Arfuso, Frank
Sethi, G.
Ahn, K.
author_sort Ko, J.
building Curtin Institutional Repository
collection Online Access
description In spite of significant advances in treatment options and the advent of novel targeted therapies, there still remains an unmet need for the identification of novel pharmacological agents for cancer therapy. This has led to several studies evaluating the possible application of natural agents found in vegetables, fruits, or plant-derived products that may be useful for cancer treatment. Bergamottin is a furanocoumarin derived from grapefruits and is also a well-known cytochrome P450 inhibitor. Recent studies have demonstrated potent anti-oxidative, anti-inflammatory, and anti-cancer properties of grapefruit furanocoumarin both in vitro and in vivo. The present review focuses on the potential anti-neoplastic effects of bergamottin in different tumor models and briefly describes the molecular targets affected by this agent.
first_indexed 2025-11-14T10:59:59Z
format Journal Article
id curtin-20.500.11937-74245
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:59:59Z
publishDate 2018
publisher MDPI AG
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-742452019-03-13T07:02:37Z Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy Ko, J. Arfuso, Frank Sethi, G. Ahn, K. In spite of significant advances in treatment options and the advent of novel targeted therapies, there still remains an unmet need for the identification of novel pharmacological agents for cancer therapy. This has led to several studies evaluating the possible application of natural agents found in vegetables, fruits, or plant-derived products that may be useful for cancer treatment. Bergamottin is a furanocoumarin derived from grapefruits and is also a well-known cytochrome P450 inhibitor. Recent studies have demonstrated potent anti-oxidative, anti-inflammatory, and anti-cancer properties of grapefruit furanocoumarin both in vitro and in vivo. The present review focuses on the potential anti-neoplastic effects of bergamottin in different tumor models and briefly describes the molecular targets affected by this agent. 2018 Journal Article http://hdl.handle.net/20.500.11937/74245 10.3390/ijms19124048 http://creativecommons.org/licenses/by/4.0/ MDPI AG fulltext
spellingShingle Ko, J.
Arfuso, Frank
Sethi, G.
Ahn, K.
Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
title Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
title_full Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
title_fullStr Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
title_full_unstemmed Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
title_short Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
title_sort pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
url http://hdl.handle.net/20.500.11937/74245